Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: Results of the CNIO-BR002 phase I-trial

  1. Quintela-Fandino, M.
  2. Bueno, M.J.
  3. Lombardia, L.
  4. Gil, M.
  5. Gonzalez-Martin, A.
  6. Marquez, R.
  7. Bratos, R.
  8. Guerra, J.
  9. Tan, E.
  10. Lopez, A.
  11. Colomer, R.
  12. Salazar, R.
Aldizkaria:
Molecular Oncology

ISSN: 1878-0261,  1574-7891

Argitalpen urtea: 2014

Alea: 8

Zenbakia: 8

Orrialdeak: 1719-1728

Mota: Artikulua

DOI: 10.1016/J.MOLONC.2014.07.005 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus